hotspot -WSS

hotspot

author：leisure time 2025-10-01 17:18:59 - browse：7193

Scientific watchdogs Sholto David (right) and Elisabeth Bik join STAT's Jonathen Wosen at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of errors in scientific papers, the problem of fraud, errors, or data mishandling in the scientific literature seems to be getting worse. In the last couple of years, Bik’s been seeing an influx of AI-generated papers in the scientific record that are “nonsensical and clearly low quality.” The possibility that AI-generated, fraudulent data could be making its way into more established journals is a constant fear.

But institutions and academic journals aren’t doing enough about it, she said at the STAT breakthrough summit in San Francisco.

While artificial intelligence can be a powerful research tool when used legitimately, it’s also “absolutely frightening to me what AI can generate,” Bik said. “I’m worried this has already infiltrated scientific literature. It’s hard to tell [AI-generated images] apart from real photos. They look so real. I feel publishers are not putting [in] enough effort to deal with it — how do we find the fake photos?”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： It's been 20 years since Dolly the sheep. Where's my clone?

WSS

Insmed lung disease drug hits target in key Phase 3 trial

Health insurers say they are turning to AI to cut costs, improve care

Second xenotransplant done with gene

FDA panel to weigh approval of NurOwn, controversial ALS drug

Akili, maker of video game for ADHD, to be acquired for 34 million

How Vertex's cystic fibrosis drug is changing patients' lives

focus

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

focus

Continuity nursing helped my family in our darkest PICU moments

Heat waves linked to early deliveries, preterm births in new study

What does generative AI mean for health care? We asked experts

Insmed lung disease drug hits target in key Phase 3 trial

Guidelines to prevent youth baseball injuries need more muscle

CDC's new outbreak response network to include Northeastern

Wildfire smoke exposes gaps in outdoor worker protections

Startling documents reveal new facets of Sacklers' opioid empire

Alkermes shareholders re

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Wikipedia

Lasker Awards 2023: Winners in biomedical research

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

Report: NIH

Intarcia’s device

Lasker Awards 2023: Winners in biomedical research

Latest bird flu infection made farmworker sicker than earlier cases

focus

focus

knowledge

hotspot